Trial NCT02444793

View at ClinicalTrials.gov 
Org. Study IDs: B1641004

Last trial update was posted on 2019-02-27

MeSH Interventions

Mogamulizumab

MeSH Conditions

Neoplasms

Other Conditions

Advanced/Metastatic Solid Tumors

Stopping Reasons

The study was terminated due to marginal efficacy and change in sponsor prioritization. The combination had a manageable safety profile.

Limitations And Caveats

The study was terminated due to marginal efficacy and change in sponsor prioritization. No participants were enrolled in the dose-expansion portion.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID